The identities and genomic locations of lipodystrophy-associated DNA sequence variants were documented for 38 of the 42 patients (90%) based on available medical records; of these, 36 patients had variants that were classified as pathogenic while two patients (one each with CGL1 and CGL4) had variants of uncertain significance. The gene discussed is CAVIN1; the disease is lipodystrophy.